The US government shut down one Saturday Baltimore plant that ruined 15 million doses of Johnson & Johnson’s Covid-19 vaccine by making the by-developed vaccine AstraZeneca Plc, the New York Times reported.
J&J said in a statement that it “took full responsibility for drug substance manufacturing for its Covid-19 vaccine at Emergent BioSolutions Inc.’s Bayview facility”
It has not specified whether it will take over the plant. The company did not respond to Reuters requests for comment for clarification.
The New York Times reported that AstraZeneca said in a statement it will work with President Joe Biden’s administration to find an alternative site. The drugmaker did not respond to a request for comment.
The U.S. Department of Health and Human Services’ move will ensure that the Emergent BioSolutions facility is dedicated solely to making the single-dose Johnson & Johnson vaccine, and is intended to avoid future confusion, it said. newspaper report, citing two. senior federal health officer
The US government’s top infectious disease doctor told Reuters the country may not need the AstraZeneca vaccine, even if it gets approval.